New and improved methods to characterize glycemic variability using continuous glucose monitoring

Diabetes Technology and Therapeutics

Volumn 11, Issue 9, 2009, Pages 551-565

  Rodbard, David ^a  

^a Biomedical Informatics Consultants LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; HUMAN; PRIORITY JOURNAL; TIME SERIES ANALYSIS;

ALGORITHMS; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; DATA INTERPRETATION, STATISTICAL; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; MONITORING, AMBULATORY; NORMAL DISTRIBUTION; NUMERICAL ANALYSIS, COMPUTER-ASSISTED; RISK FACTORS; STATISTICS AS TOPIC; TIME FACTORS;

EID: 70349314777     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2009.0015     Document Type: Article

References (44)

1. Hirsch IB: Glycemic variability: it's not just about A1C anymore! Diabetes Technol Ther 2005;7:780-783.
2. Hirsch IB, Brownlee M: The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 2007;30:186-187.
3. Brownlee M, Hirsch IB: Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA 2006;295:1707-1708.
4. Hirsch IB, Brownlee M: Should minimal blood glucose variability become the gold standard of glycemic control? J Diabetes Complications 2005;19:178-181.
5. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglyce-mia in patients with type 2 diabetes. JAMA 2006;295:1681-1687.
6. Wentholt IM, Kulik W, Michels RP, Hoekstra JB, DeVries JH: Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes. Diabetologia 2008;51:183-190.
7. Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, Giugliano D: Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes 2008;57:1349-1354.
8. Ceriello A, Kumar S, Piconi L, Esposito K, Giugliano D: Simultaneous control of hyperglycemia and oxidative stress normalizes endothelial function in type 1 diabetes. Diabetes Care 2007;30:649-654.
9. Diabetes Research in Children Network (DirecNet) Study Group: The effect of glucose variability on the risk of mi-crovascular complications in type 1 diabetes. Diabetes Care 2007;30:185.
10. Kilpatrick ES, Rigby AS, Atkin SL: The effect of glucose variability on the risk of microvascular complications in type 1 diabetes. Diabetes Care 2006;29:1486-1490.
11. Kilpatrick ES, Rigby AS, Atkin SL: HbA1c variability and the risk of microvascular complications in type 1 diabetes: data from the DCCT [abstract 817-P]. Diabetes 2008;57(Suppl 1): A236.
12. Rodbard D: Optimizing display, analysis, interpretation and utility of self-monitoring of blood glucose (SMBG) data for management of patients with diabetes. J Diabetes Sci Tech-nol 2007;1:62-71.
13. Garg S, Jovanovic L: Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care 2006;29:2644-2649.
14. Rodbard D, Jovanovic L, Garg SK, Matsubara BS, Nakamura K, Bailey T, Zisser H, Kaplan R: Reduced glycemic variability with the use of real-time continuous glucose monitoring [abstract 208-OR]. Diabetes 2009;58(Suppl 1).
15. Rodbard D, Bailey T, Jovanovic L, Zisser H, Kaplan R, Garg S: Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. Diabetes Technol Ther 2009;11(in press) and accompanying online Appendix.
16. Rodbard D, Jovanovic L, Garg S: Impact of continuous glucose monitoring (CGM) on glycemic variability and control in subjects with type 1 diabetes using multiple daily injections (MDI) vs. insulin pump [abstract 2-LB]. http:== ww2.aievolution.com=ada0901=index.cfm?doabs.pubSearch Abstracts (accessed June 30, 2009).
17. Rodbard D: Interpretation of continuous glucose monitoring data: glycemic variability and quality of glycemic control. Diabetes Technol Ther 2009;11(Suppl 1):S-55-S-67.
18. Pernick NL, Rodbard D: Personal computer programs to assist with self-monitoring of blood glucose and self-adjustment of insulin dosage. Diabetes Care 1986;9:61-69.
19. Rodbard D: Potential role of computers in clinical investigation and management of diabetes mellitus. Diabetes Care 1988;11(Suppl 1):54-61.
20. Mazze RS, Lucido D, Langer O, Hartmann K, Rodbard D: Ambulatory glucose profile: representation of verified self-monitored blood glucose data. Diabetes Care 1987;10:111-117.
21. Mazze RS, Strock E, Wesley D, Borgman S, Morgan B, Ber-genstal R, Cuddihy R: Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis. Diabetes Technol Ther 2008;10:149-159.
22. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF: Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970;19:644-655.
23. Service FJ, Nelson RL: Characteristics of glycemic stability. Diabetes Care 1980;3:58-62.
24. Service FJ, O'Brien PC, Rizza RA: Measurements of glucose control. Diabetes Care 1987;10:225-237.
25. McDonnell CM, Donath SM, Vidmar SI, Werther GA, Cameron FJ: A novel approach to continuous glucose analysis utilizing glycemic variation. Diabetes Technol Ther 2005;7:253-263.
26. Kuenen JC, Borg R, Zheng H, Schoenfeld D, Heine RJ, Nathan DM; the ADAG Study Group: Does glucose variability influence the relationship between average glucose and HbA1c levels? [abstract 848-P]. Diabetes 2008;57(Suppl 1): A245.
27. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; the Alc-Derived Average Glucose (ADAG) Study Group: Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31:1473-1478.
28. Schlichtkrull J, Munck O, Jersild M: The M-value, an index of blood-sugar control in diabetics. Acta Med Scand 1965; 177:95-102.
29. Wójcicki JM: Mathematical descriptions of the glucose control in diabetes therapy. Analysis of the Schlichtkrull ''M''-value. Horm Metab Res 1995;27:1-5.
30. Wójcicki JM: ''J''-index. A new proposition of the assessment of current glucose control in diabetic patients. Horm Metab Res 1995;27:41-42.
31. Kovatchev BP, Otto E, Cox D, Gonder-Frederick L, Clarke W: Evaluation of a new measure of blood glucose variability in diabetes. Diabetes Care 2006;29:2433-2438.
32. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Clarke W: Symmetrization of the blood glucose measurement scale and its applications. Diabetes Care 1997;20:1655-1658.
33. Kovatchev BP, Cox DJ, Gonder-Frederick LA, Young-Hyman D, Schlundt D, Clarke W: Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucoseindex. Diabetes Care 1998;21:1870-1875.
34. Hill NR, Hindmarsh PC, Stevens RJ, Stratton IM, Levy JC, Matthews DR: A method for assessing quality of control from glucose profiles. Diabet Med 2007;24:753-758.
35. Rodbard D: Improved methods for calculating a ''figure of merit'' for blood glucose monitoring data [abstract]. J Diabetes Sci Technol 2007;1:438.
36. Ryan EA, Shandro T, Green K, Paty BW, Senior PA, Bigam D, Shapiro AM, Vantyghem MC: Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 2004;53:955-962.
37. Paty BW, Senior PA, Lakey JR, Shapiro AM, Ryan EA: Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects. Diabetes Technol Ther 2006;8:165-173.
38. Efron B: Bootstrap methods: another look at the jackknife. Ann Stat 1979;7:1-26.
39. Tibshirani RJ: Monographs on Statistics and Applied Probability: An Introduction to the Bootstrap. Boca Raton, FL: CRC Press, 1994.
40. Xycoon: Descriptive Statistics-Variability-Relationship Between Mean Absolute Deviation, Quartile Differences and Standard Deviation. http: =www.xycoon.com=relationships1.htm (accessed June 15 2009).
41. Absolute Deviation. http:==en.wikipedia.org=wiki=Absolute-Deviation (accessed June 15, 2009).
42. JDRF CGM Study Group: JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods. Diabetes Technol Ther 2008;10:310-321.
43. Kovatchev B, Clarke W: Peculiarities of the continuous glucose monitoring data stream and their impact on developing closed-loop control technology. J Diabetes Sci Technol 2008;2:158-163.
44. Rodbard D, Jovanovic L, Garg S: Responses to continuous glucose monitoring (CGM) in subjects with type 1 diabetes using continuous subcutaneous insulin infusion (CSII) or multiple daily injections (MDI). Diabetes Technol Ther 2009; 11(12): in press.